Brief: China Pharma Announces Receipt Of Notification Of NYSE American Listing Deficiency
02/10/2022 03:10
Oct 1 (Reuters) - China Pharma Holdings Inc CPHI.A :
* CHINA PHARMA ANNOUNCES RECEIPT OF NOTIFICATION OF NYSE
AMERICAN
LISTING DEFICIENCY
* CHINA PHARMA- ON SEPT 26, 2022 RECEIVED NOTIFICATION FROM
NYSE
AMERICAN INFORMING IT THAT CO IS NOT IN COMPLIANCE WITH CERTAIN
NYSE LISTING STANDARDS
* CO'S STOCK WILL CONTINUE TO BE LISTED ON NYSE AMERICAN
WHILE IT
ATTEMPTS TO REGAIN COMPLIANCE WITH LISTING STANDARDS
Source text for Eikon: ID:nPnbs09G6a
Further company coverage: CPHI.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Pharma Holdings
See all newsBrief: China Pharma - Not Aware Of Any Material Corporate Developments Explaining Recent Market Activity
Brief: China Pharma Says Co Knows Of No Events That Could Have Caused Unusual Market Activity
Brief: China Pharma Holdings Inc - NYSE American Contacts China Pharma Regarding Unusual Market Activity On May 12 And 13
Brief: China Pharma Holdings Files For Non-Timely 10-K With US SEC
Brief: China Pharma Holdings Inc. Announces 1-For-10 Reverse Stock Split